An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented. The guidelines are based on a systematic evidence review, contributions from 6 working groups, and a recent symposium cosponsored by the ACS, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology, which was attended by 25 organizations. The new screening recommendations address age‐appropriate screening strategies, including the use of cytology and high‐risk human papillomavirus (HPV) testing, follow‐up (eg, the management of screen positives and screening intervals for screen negatives) of women after screening, the age at which to exit screening, future considerations regarding HPV testing alone as a primary screening approach, and screening strategies for women vaccinated against HPV16 and HPV18 infections. CA Cancer J Clin 2012. © 2012 American Cancer Society.

中文翻译：

---

美国癌症协会、美国阴道镜和宫颈病理学会以及美国临床病理学会预防和早期检测宫颈癌的筛查指南

美国癌症协会 (ACS) 关于宫颈癌前病变和癌症早期筛查筛查指南的更新现已发布。该指南基于系统的证据审查、6 个工作组的贡献以及最近由 ACS、美国阴道镜和宫颈病理学会以及美国临床病理学会共同主办的研讨会（有 25 个组织参加）。新的筛查建议涉及适合年龄的筛查策略，包括使用细胞学和高危人乳头瘤病毒（HPV）检测、筛查后女性的随访（例如筛查阳性的管理和筛查阴性的筛查间隔），退出筛查的年龄、单独将 HPV 检测作为主要筛查方法的未来考虑因素，以及针对接种 HPV16 和 HPV18 感染疫苗的女性的筛查策略。CA Cancer J Clin 2012。© 2012 美国癌症协会。